Hypoxia-inducible factor: Achilles' heel of antiangiogenic cancer therapy (review).

International journal of oncology

Volumn 19, Issue 2, 2001, Pages 257-262

  Blagosklonny, M V ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; DNA BINDING PROTEIN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

ANOXIA; HUMAN; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; REVIEW; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANOXIA; DNA-BINDING PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASMS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

MLCS; MLOWN;

EID: 0035432151     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.19.2.257     Document Type: Review

References (82)